Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.65 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.65 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | IGF2R | P11717 | 2/20 | 0.48 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.48 |
| ▸ | IFNG | P01579 | 1/20 | 0.47 |
| ▸ | FGF1 | P05230 | 1/20 | 0.47 |
| ▸ | FGF2 | P09038 | 1/20 | 0.47 |
| ▸ | BMP2 | P12643 | 1/20 | 0.47 |
| ▸ | VEGFA | P15692 | 1/20 | 0.47 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.47 |
| ▸ | BDNF | P23560 | 2/20 | 0.45 |
| ▸ | PTN | P21246 | 1/20 | 0.45 |
| ▸ | MDK | P21741 | 1/20 | 0.45 |
| ▸ | SIGLEC7 | Q9Y286 | 3/20 | 0.44 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.44 |
| ▸ | CD69 | Q07108 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19404388 | 1.00 | LGALS8 (0.65) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL19404390 | 1.00 | LGALS8 (0.65) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL15482021 | 0.98 | LGALS8 (0.67) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL18011604 | 0.98 | LGALS8 (0.67) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL13541646 | 0.98 | LGALS8 (0.67) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL18608298 | 0.98 | LGALS8 (0.67) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL18620664 | 0.98 | LGALS8 (0.67) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL19404689 | 0.97 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL13541636 | 0.96 | LGALS8 (0.60) | LGALS8LGALS3LGALS4MAPK1IGF2R | |
| SCHEMBL22180491 | 0.96 | LGALS8 (0.60) | LGALS8LGALS3LGALS4MAPK1IGF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275389-A1 | NOVEL GLYCAN CONJUGATES AND USE THEREOF | ACADEMIA SINICA (TW) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275389-A1 | NOVEL GLYCAN CONJUGATES AND USE THEREOF | STT3B, ST3GAL3, FUT6 | LGALS8 28/4885LGALS3 43/4885LGALS4 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.